Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

AGM Statement

22 Mar 2022 07:00

RNS Number : 5240F
Crest Nicholson Holdings PLC
22 March 2022
 

Crest Nicholson Holdings plc

 (the 'Group' or 'Crest Nicholson')

 

STRONG TRADING PERFORMANCE

EXPANSION PLANS ON TRACK

Crest Nicholson Holdings plc is holding its Annual General Meeting ('AGM') at 10:00 a.m. today. This trading update is for the period from 1 November 2021 to 21 March 2022. The Company's FY22 year end is on 31 October 2022.

Trading update

The Group has delivered a strong trading performance since the start of the financial year. Housing market conditions remain favourable and we continue to see good demand for our homes. Our private SPOW1 rate in the last eight weeks was 0.98, reflecting strong sales momentum continuing since our reported FY21 sales rate of 0.80.

As of 18 March 2022, our order book is over 84% covered for FY22 revenue, up from 63% as reported at our preliminary results in January. This represents a strong forward order position, providing good visibility and confidence in meeting our revenue targets for the current financial year. Input cost inflation is likely to increase because of rising energy costs and raw material supply disruption caused by the tragic conflict in Ukraine and is already starting to be seen. However, as illustrated during the COVID-19 pandemic, the Group has demonstrated its effectiveness at managing its supply chain in turbulent times. In addition, we are also currently managing to successfully offset cost increases through sales price inflation.

Our expansion plans are progressing well. Having appointed the business leader for our new Yorkshire division we have also moved into our office in Leeds. We are now focused on establishing the new team who are actively pursuing several land opportunities. We have also identified a business leader for our East Anglia division who is expected to join in June 2022. An office location has been identified and we expect to be operational in this region in the second half of 2022.

We continue to make good progress against our existing sustainability targets and are on track to announce our science-based targets before our half year results in June 2022.

The Group continues to review and remediate legacy buildings in accordance with the operational and financial guidance provided at our preliminary results in January 2022. The Group is also actively participating in the present and ongoing dialogue with the Government on this subject, via the HBF, and will provide an update on the outcome of any discussions as soon as it appropriate to do so.

The current macro and geopolitical uncertainties will clearly present fresh challenges for housebuilders to navigate. However, the Board remains confident about Crest Nicholson's medium-term prospects. Demand for housing continues to outstrip supply and Crest Nicholson has a clear growth strategy in place to capitalise on these market conditions. Our operating model is highly efficient and is supported by a strong balance sheet, which will underpin growth in future earnings and provides resilience in times of uncertainty.

The Group expects to announce its half year results for the six months ending 30 April 2022 on 14 June 2022.

AGM meeting

The Group will be holding its AGM today at 10:00 a.m. at the Group's office: Crest House, Pyrcroft Road, Chertsey, Surrey KT16 9GN.

1.Sales per outlet per week

 

For further information, please contact:

Crest Nicholson

 

Jenny Matthews, Head of Investor Relations

 

 

 

+44 (0) 7557 842720

Tulchan Communications

 

James Macey White / Giles Kernick

 

 

 

+44 (0) 20 7353 4200

 

22 March 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEUEFFEESEDD
Date   Source Headline
3rd Aug 20173:45 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:40 pmRNSDirector/PDMR Shareholding
27th Jun 20177:00 amRNSAnalyst & Investor Day
13th Jun 20177:00 amRNSHalf-year Report
30th May 20175:08 pmRNSHolding(s) in Company
25th May 20172:47 pmRNSDirector Declaration
16th May 20177:00 amRNSTrading Update
28th Apr 20173:24 pmRNSTotal Voting Rights
25th Apr 20171:53 pmRNSDirectorate Change
24th Apr 20174:03 pmRNSDirector/PDMR Shareholding
18th Apr 201710:52 amRNSBlock listing Interim Review
11th Apr 20173:54 pmRNSDirector/PDMR Shareholding
6th Apr 201711:45 amRNSDirector/PDMR Shareholding
30th Mar 20179:41 amRNSDirector/PDMR Shareholding
23rd Mar 20172:12 pmRNSResult of AGM
23rd Mar 20177:00 amRNSAGM Statement
9th Mar 20174:44 pmRNSDirector/PDMR Shareholding
9th Mar 20174:39 pmRNSDirector/PDMR Shareholding
6th Mar 201710:10 amRNSDirector Declaration
3rd Mar 20174:27 pmRNSHolding(s) in Company - Replacement
3rd Mar 20174:00 pmRNSTotal Voting Rights
3rd Mar 20179:49 amRNSDirector/PDMR Shareholding
28th Feb 20176:02 pmRNSTotal Voting Rights
23rd Feb 20174:26 pmRNSDirector/PDMR Shareholding
20th Feb 20176:12 pmRNSHolding(s) in Company
17th Feb 20176:04 pmRNSHolding(s) in Company
13th Feb 201712:08 pmRNSDirectorate Change
13th Feb 201711:59 amRNSAnnual Financial Report
8th Feb 20174:42 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSAdditional Listing
24th Jan 20177:00 amRNSFinal Results
10th Jan 20172:57 pmRNSDirectorate Change
6th Jan 20174:09 pmRNSHolding(s) in Company
3rd Jan 20177:00 amRNSTotal Voting Rights
30th Nov 20165:13 pmRNSTotal Voting Rights
28th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 20163:49 pmRNSHolding(s) in Company
15th Nov 20167:00 amRNSTrading Statement
31st Oct 20164:54 pmRNSTotal Voting Rights
24th Oct 20166:17 pmRNSHolding(s) in Company
21st Oct 20163:18 pmRNSHolding(s) in Company
19th Oct 20162:20 pmRNSHolding(s) in Company
17th Oct 20162:35 pmRNSBlock listing Interim Review
17th Oct 20162:28 pmRNSHolding(s) in Company
14th Oct 20164:27 pmRNSHolding(s) in Company
30th Sep 20164:02 pmRNSTotal Voting Rights
22nd Sep 20162:31 pmRNSDirector/PDMR Shareholding
22nd Sep 20162:29 pmRNSDirector/PDMR Shareholding
15th Sep 20168:58 amRNSHolding(s) in Company
14th Sep 20165:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.